RV Produkt Pembrolizumab
TED · 705748-2026Contract noticeCloses in 34 days · 2026-11-16
Buyer
NameLandeskrankenanstalten-Betriebsgesellschaft - KABEG
CountryAT
Published2026-10-13
Deadline2026-11-16
Value
Estimated—
Awarded—
Who already wins at this buyer
Firms with recorded awards from Landeskrankenanstalten-Betriebsgesellschaft - KABEG in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| GE Healthcare Austria GmbH & Co OG | 1 | €4,442,690 | 2026-06-25 |
| Roche Austria GmbH | 1 | €3,889,440 | 2026-05-28 |
| Abbvie GmbH | 1 | €2,914,283 | 2026-06-30 |
| Bayer Austria Ges.m.b.H. | 1 | €960,091 | 2026-05-28 |
| Cancom Austria AG | 1 | €632,731 | 2026-08-13 |
Full buyer profile: what Landeskrankenanstalten-Betriebsgesellschaft - KABEG buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Rahmenvereinbarung für das Produkt Pembrolizumab
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-10-13 | RV Produkt Zolbetuximab | Landeskrankenanstalten-Betriebsgesellschaft - KABEG AT | 96% |
| 2026-06-30 | RV aktive Exoskelette | Landeskrankenanstalten-Betriebsgesellschaft - KABEG AT | 96% |
| 2026-06-03 | Liefervereinbarung Blenrep | Landeskrankenanstalten-Betriebsgesellschaft - KABEG AT | 95% |
| 2026-05-28 | Liefervereinbarung Faricimab | Landeskrankenanstalten-Betriebsgesellschaft - KABEG AT | 95% |
| 2026-05-28 | Liefervereinbarung Aflibercept | Landeskrankenanstalten-Betriebsgesellschaft - KABEG AT | 94% |
| 2026-06-30 | Liefervereinbarung Elahere | Landeskrankenanstalten-Betriebsgesellschaft - KABEG AT | 94% |